We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPECW
2226
CALL
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
$665K ﹤0.01%
64,792
-204,930
-76% -$6.35K
GNRC icon
2227
Generac Holdings
GNRC
$11.5B
$665K ﹤0.01%
6,610
+3,637
+122% +$412K
CF icon
2228
PUT
CF Industries
CF
$19.6B
$665K ﹤0.01%
+7,800
New +$792K
VKTX icon
2229
Viking Therapeutics
VKTX
$3.88B
$661K ﹤0.01%
70,335
-1,267,045
-95% -$5.66M
WESTW
2230
CALL
DELISTED
Westrock Coffee Company Warrants
WESTW
$654K ﹤0.01%
48,956
-271,044
-85% -$432K
KMPR icon
2231
Kemper
KMPR
$1.81B
$654K ﹤0.01%
+13,286
New +$668K
AEHR icon
2232
Aehr Test Systems
AEHR
$2.13B
$653K ﹤0.01%
32,491
+8,376
+35% +$179K
EVGR
2233
DELISTED
Evergreen Corporation Class A Ordinary Share
EVGR
$649K ﹤0.01%
63,102
UNFI icon
2234
United Natural Foods
UNFI
$3.04B
$649K ﹤0.01%
16,757
-82,164
-83% -$3.4M
SNBR
2235
DELISTED
Sleep Number
SNBR
$648K ﹤0.01%
24,958
-61,026
-71% -$1.85M
CRMD icon
2236
CorMedix
CRMD
$564M
$647K ﹤0.01%
153,375
+110,298
+256% +$390K
COLB icon
2237
Columbia Banking Systems
COLB
$8.71B
$646K ﹤0.01%
21,453
-185,701
-90% -$5.9M
GLSI icon
2238
Greenwich LifeSciences
GLSI
$188M
$646K ﹤0.01%
42,503
-34,420
-45% -$394K
WBD icon
2239
Warner Bros
WBD
$64.3B
$644K ﹤0.01%
+67,930
New +$767K
QTEC icon
2240
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.33B
$643K ﹤0.01%
+6,113
New +$658K
RAD
2241
DELISTED
Rite Aid Corporation
RAD
$643K ﹤0.01%
192,369
+109,935
+133% +$522K
BVH
2242
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$642K ﹤0.01%
25,720
-56,067
-69% -$1.16M
KIDS icon
2243
OrthoPediatrics
KIDS
$513M
$641K ﹤0.01%
+16,122
New +$672K
KODK icon
2244
Kodak
KODK
$809M
$640K ﹤0.01%
209,905
+195,660
+1,374% +$860K
RRGB icon
2245
Red Robin
RRGB
$139M
$640K ﹤0.01%
114,705
+11,241
+11% +$83.7K
LPRO
2246
Open Lending Corp
LPRO
$372M
$640K ﹤0.01%
94,743
-129,198
-58% -$909K
IHAK icon
2247
iShares Cybersecurity and Tech ETF
IHAK
$988M
$638K ﹤0.01%
19,331
+4,936
+34% +$168K
HBNC icon
2248
Horizon Bancorp
HBNC
$1.06B
$637K ﹤0.01%
+42,229
New +$696K
UGI icon
2249
UGI
UGI
$7.87B
$637K ﹤0.01%
+17,173
New +$621K
RONI.WS
2250
CALL
DELISTED
Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
RONI.WS
$636K ﹤0.01%
62,495

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.